Lisa von Moltke - 17 Mar 2025 Form 3 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Role: Head of Research and Development and Chief Medical Officer. Exhibit List: Exhibit 24 - Power of Attorney.
Signature: By: /s/ Chase Jayasekera, Attorney-in-Fact
Issuer symbol: ZBIO
Transactions as of: 17 Mar 2025
Net transactions value: $0
Form type: 3
Filing time: 21 Mar 2025, 16:01:08 UTC
Previous filing: 19 Feb 2025
Next filing: 17 Apr 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Head of Research and Development and Chief Medical Officer. Exhibit List: Exhibit 24 - Power of Attorney.